DK0808154T3 - Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer - Google Patents

Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer

Info

Publication number
DK0808154T3
DK0808154T3 DK96904552T DK96904552T DK0808154T3 DK 0808154 T3 DK0808154 T3 DK 0808154T3 DK 96904552 T DK96904552 T DK 96904552T DK 96904552 T DK96904552 T DK 96904552T DK 0808154 T3 DK0808154 T3 DK 0808154T3
Authority
DK
Denmark
Prior art keywords
formulations
compounds
fatty acids
nanoparticle dispersions
digestible oils
Prior art date
Application number
DK96904552T
Other languages
Danish (da)
English (en)
Inventor
W Mark Eickhoff
Karl R Mueller
David A Engers
Original Assignee
Elan Pharma Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/384,057 external-priority patent/US5571536A/en
Priority claimed from US08/388,088 external-priority patent/US5560931A/en
Application filed by Elan Pharma Int Ltd filed Critical Elan Pharma Int Ltd
Application granted granted Critical
Publication of DK0808154T3 publication Critical patent/DK0808154T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96904552T 1995-02-06 1996-01-31 Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer DK0808154T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/384,057 US5571536A (en) 1995-02-06 1995-02-06 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US08/388,088 US5560931A (en) 1995-02-14 1995-02-14 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
PCT/US1996/001433 WO1996024332A1 (en) 1995-02-06 1996-01-31 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids

Publications (1)

Publication Number Publication Date
DK0808154T3 true DK0808154T3 (da) 2001-04-30

Family

ID=27010448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96904552T DK0808154T3 (da) 1995-02-06 1996-01-31 Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer

Country Status (11)

Country Link
EP (1) EP0808154B1 (el)
JP (1) JPH10513200A (el)
AT (1) ATE198148T1 (el)
AU (1) AU4862796A (el)
CA (1) CA2207304A1 (el)
DE (1) DE69611287T2 (el)
DK (1) DK0808154T3 (el)
ES (1) ES2154806T3 (el)
GR (1) GR3035613T3 (el)
PT (1) PT808154E (el)
WO (1) WO1996024332A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
US6337092B1 (en) 1998-03-30 2002-01-08 Rtp Pharma Inc. Composition and method of preparing microparticles of water-insoluble substances
ATE318132T1 (de) * 1998-03-30 2006-03-15 Jagotec Ag Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung
US6869617B2 (en) 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
IL160570A0 (en) 2001-09-26 2004-07-25 Baxter Int Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
WO2010079037A2 (de) * 2008-12-18 2010-07-15 Basf Se Wässrige dispersion umfassend pestizidpartikel und amphiphil

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9300875D0 (en) * 1993-01-18 1993-03-10 Ucb Sa Nanocapsule containing pharmaceutical compositions

Also Published As

Publication number Publication date
PT808154E (pt) 2001-06-29
JPH10513200A (ja) 1998-12-15
DE69611287D1 (de) 2001-01-25
EP0808154B1 (en) 2000-12-20
ES2154806T3 (es) 2001-04-16
DE69611287T2 (de) 2001-08-09
EP0808154A1 (en) 1997-11-26
WO1996024332A1 (en) 1996-08-15
CA2207304A1 (en) 1996-08-15
ATE198148T1 (de) 2001-01-15
AU4862796A (en) 1996-08-27
GR3035613T3 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
DK0808154T3 (da) Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer
CA2190485A1 (en) Lacrimal gland specific emulsions for topical application to ocular tissue
BR9800890A (pt) Microemulsão
ES2168271T3 (es) Composiciones farmaceuticas que contienen ciclosporinas.
DE3579069D1 (de) Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung.
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
ATE207346T1 (de) Orale pharmazeutische zusammensetzungen mit sexualhormonen
ATE206632T1 (de) Nanoemulsion aus fettsäureestern von phosphorsäure und deren verwendung in kosmetika, dermatologie, pharmazeutika und/oder ophthalmologie
KR940018091A (ko) 불포화 지방산을 포함하는 처방
DE69900328T2 (de) Nanoemulsion aus Fettsäureestern von Glycerin und deren Verwendungen in Kosmetika, Dermatologie und/oder Ophthalmologie
EP1072249A3 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
KR950031034A (ko) 화장품 또는 피부과용 조성물 및 그의 제법
DE50012804D1 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
US6280755B1 (en) Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
EP1072247A3 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
ATE101036T1 (de) Aktivitaetspotenziator gegen krebs.
US6979459B1 (en) Treatment of skin damage using polyenylphosphatidycholine
YU13302A (sh) Parenteralna emulzija cisplatina
DE69713896T2 (de) Pharmazeutische formulierungen zur topischen verwendung mit vit. e acetate
AR019810A1 (es) Mezclas de lipidos y su uso.
JP2005008591A (ja) 乳化・可溶化皮膚外用剤
JPH0717860A (ja) 脂溶性物質含有液剤および脂溶性物質の乳化・可溶化方法
GB2362105A (en) Aciclovir compositions containing dimethicone
JP2004196665A (ja) スティギングを抑制した化粧料
KR920019344A (ko) α-리놀렌산을 이용한 간장질환의 예방 및 치료 조성물